RISPEFAR 4 MG

국가: 이스라엘

언어: 영어

출처: Ministry of Health

유효 성분:

RISPERIDONE 4 MG

제공처:

PHARMALOGIC LTD

ATC 코드:

N05AX08

약제 형태:

FILM COATED TABLETS

관리 경로:

PER OS

Manufactured by:

SPECIFAR S.A., GREECE

치료 그룹:

RISPERIDONE

치료 징후:

Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. Risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Risperidone is indicated for the treatment of psychotic manifestations of dementia. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years. Risperidone is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

승인 날짜:

2011-03-01